ID Source | ID |
---|---|
PubMed CID | 119577 |
CHEBI ID | 165889 |
SCHEMBL ID | 16097635 |
MeSH ID | M0151432 |
Synonym |
---|
l-cysteine, n-acetyl-s-(trichloroethenyl)- |
s-trichlorovinyl-n-acetylcysteine |
n-acetyl-s-(trichloroethenyl)-l-cysteine |
ccris 1307 |
(2r)-2-acetamido-3-(1,2,2-trichloroethenylsulanyl)propanoic acid |
111348-61-9 |
n-acetyl-s-(trichlorovinyl)-cysteine |
CHEBI:165889 |
(2r)-2-acetamido-3-(1,2,2-trichloroethenylsulfanyl)propanoic acid |
n-acetyl-s-(trichlorovinyl)cysteine |
unii-okq3s0ej8y |
okq3s0ej8y , |
n-acetyl-s-(trichlorovinyl)-l-cysteine |
l-cysteine,n-acetyl-s-(1,2,2-trichloroethenyl)- |
SCHEMBL16097635 |
n-acetyl-s-(1,2,2-trichlorovinyl)-l-cysteine |
l-cysteine, n-acetyl-s-(1,2,2-trichloroethenyl)- |
DTXSID20149602 |
J-002563 |
AKOS030240573 |
(2r)-2-acetamido-3-(1,2,2-trichlorovinylsulfanyl)propanoic acid |
Q27896755 |
(r)-2-acetamido-3-((1,2,2-trichlorovinyl)thio)propanoic acid |
STARBLD0019568 |
(2r)-2-acetamido-3-[(1,2,2-trichloroethenyl)sulfanyl]propanoic acid |
Excerpt | Relevance | Reference |
---|---|---|
" Data are also presented for the isolation and analysis of this compound obtained from dosed rats." | ( Quantitation of the tetrachloroethylene metabolite N-acetyl-S-(trichlorovinyl)cysteine in rat urine via negative ion chemical ionization gas chromatography/tandem mass spectrometry. Bartels, MJ, 1994) | 0.29 |
Class | Description |
---|---|
N-acyl-L-amino acid | Any N-acylamino acid having L-configuration. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.67) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |